Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
AGORACOM NEWS FLASH

Drill Program Encounters 2.45 g/t Pd+Pt+Au Over 28 m at the River Valley Platinum Group Metals PGM Project, Sudbury Mining District

  • A drill hole collared in main mineralized zone (Dana North) encountered 2.45 g/t Pd+Pt+Au over 28m, including 7.12 g/t over 3m and 4.06 g/t over 6m with a second zone of 3.30 g/t Pd+Pt+Au over 4m
  • Drilling continues to encounter PGM mineralization in the footwall of the River Valley PGM Deposit with assays of 1.56 g/t Pd+Pt+Au over 9m, 1.41 g/t over 8m, 1.12 g/t over 17 m and 1.64 m of 7m were obtained from drilling in the footwall
  • River Valley is the Largest Undeveloped Primary PGM resource in Canada, with 3.9Moz PdEq in Measured Plus Indicated including an additional 1.2Moz PdEq in Inferred.

New age large

Hub On AGORACOM / Read Release

Message: 2 Things to Watch at MannKind Corporation

Aside from not proof reading the copy the logic seems flawed in this statement:

"Given his knowledge of this industry -- and the many lessons learned from Exubera's failure -- Dance's product could be an improved, next-generation insulin that might better serve the needs of diabetes patients. Its product is still in early development, but this is (a) something investors should keep an eye on."

Just because somebody was associated with a screw up doesn't mean they learn from the mistake. That would be like naming our current president to be the Fed chairman after racking up 8 years of trillion dollar deficits.

This article seems more like FUD for MNKD and pumping Dance to me. Why would Dance be more capable of bringing an inhaled insulin to market if as is indiacted earlier in the article it is unclear whether or not inhaled insulin will be embraced by the market? Absolutely nothing is said regarding the efficacy, safety or benefits of Afrezza.

Swing

Share
New Message
Please login to post a reply